Quanterix Corp

Quanterix insider deals reveal new RSU and option grants for C‑level executive, signaling long‑term confidence amid short‑term trade volatility and market headwinds.

Insider buying at Quanterix shows CFO Sriram Vandana’s confidence in a potential FDA‑cleared Alzheimer’s test, hinting at upside amid a low‑price, negative‑P/E stock.

Quanterix insider buy signals long‑term confidence: director’s 23k zero‑cost R‑stock units suggest optimism amid exec sell‑offs, hinting at future upside.